Since abnormal post-translational modifi cations or gene mutations of tau have been detected in over twenty neurodegenerative disorders, tau has attracted widespread interest as a target protein. Among its various post-translational modifications, phosphorylation is the most extensively studied. It is recognized that tau hyperphosphorylation is the root cause of neurodegeneration in Alzheimer's disease (AD); however, it is not clear how it causes neurodegeneration. Based on the findings that tau hyperphosphorylation leads to the escape of neurons from acute apoptosis and simultaneously impairs the function of neurons, we have proposed that the nature of AD neurodegeneration is the consequence of aborted apoptosis induced by tau phosphorylation. Therefore, proper manipulation of tau hyperphosphorylation could be promising for arresting AD neurodegeneration. In this review, the neuroprotective and neurodegenerative effects of tau hyperphosphorylation and our thoughts regarding their relationship are presented. are the most involved [3][4][5] .
in the sub-ventricular zone of rat brain [20] .
The activity of protein phosphatases is decreased in the AD brain [21] . Several phosphatases such as PP2A, PP2B, and PP1 can dephosphorylate abnormally hyperphosphorylated tau isolated from AD brains; among these, PP2A is the most effective [22] [23] [24] . In vitro, PP2A
can dephosphorylate abnormal tau at multiple sites and thus restore its biological activity [5] . Inactivation of PP2A by okadaic acid, homocysteine, or zinc induces tau hyperphosphorylation/accumulation and axoplasmic transport deficits [25] [26] [27] . PP2A activity is regulated in vivo by a constitutive protein inhibitor called inhibitor 2 of PP2A (I2PP2A) that is increased in the AD brain, and phosphorylation of I2PP2A at serine-9 results in its cytoplasmic accumulation, as seen in the AD brain [28] .
Conversely, betaine and nicotinamide mononucleotide adenylyltransferase 2 can activate PP2A and attenuate tau hyperphosphorylation [29, 30] . In the astrocytes of tg2567 mice, a widely-used amyloidogenic model of AD, PP2A
is activated. This stimulates the migration of astrocytes towards amyloid plaques by inhibiting p38 MAPK, indicating that the PP2A deficit in the AD brain may cause Aβ accumulation by hindering astrocyte migration [31] .
GSK-3β activation can inhibit PP2A by upregulating protein tyrosine phosphatase 1B (PTP1B), which phosphorylates PP2A at tyrosine-307 [32, 33] , suggesting that activation of GSK-3β and inhibition of PP2A may form a vicious cycle that promotes tau hyperphosphorylation in the AD brain. Tau is also highly glycosylated through N-linked glycosidic bonds in the AD brain [34] , while a negative correlation between tau O-glycosylation and phosphorylation has been reported in a rat model of starvation [35] . A study also showed that prion protein can also inhibit tau-mediated microtubule formation [36] .
Evidence Supporting the Toxic Effects of Tau Hyperphosphorylation
Since the formation of neurofibrillary tangles from 
Tau Hyperphosphorylation Disrupts Microtubule Dynamics
Homeostatic microtubule assembly and disassembly is essential for normal cell morphology, functions, and viability, while microtubule dynamics is regulated by tau phosphorylation. The abnormally hyperphosphorylated tau isolated from AD brains and in vitro hyperphosphorylated recombinant human tau are no longer competent to promote microtubule assembly or bind to microtubules [37, 38] , and dephosphorylation dissociates tau from PHFs and restores its biological activity [22] . Hyperphosphorylation of tau not only diminishes its biological activity, but also causes it to gain toxic functions. For instance, hyperphosphorylated tau detached from microtubules sequesters normal tau and other high molecular-weight microtubule-associated proteins, thus disrupting microtubule dynamics and causing somatodendritic accumulation of tau proteins.
Hyperphosphorylation promotes tau aggregation that can block the intracellular traffi cking of neurotrophins and other functional proteins, and cause axonopathy [39] [40] [41] . Moreover, transgenic mice that overexpress the 4R human tau isoform develop axonal degeneration in specifi c neurons of the brain and spinal cord [42] .
Tau Hyperphosphorylation Promotes Tangle Formation
Normal tau binds to tubulin and promotes its assembly into microtubules, while the abnormally hyperphosphorylated form binds to normal tau and disrupts microtubules [36] . In Drosophila, only the simultaneous expression of human tau and GSK-3 or cyclin-dependent kinase-5 (Cdk-5), but not human tau alone, stimulates the formation of neurofi brillary inclusions, while reducing tau phosphorylation decreases tau aggregation in P301L mice treated with LiCl, an inhibitor of GSK-3 [43] [44] [45] . In vitro study has also shown that phosphorylation of all six recombinant human brain isoforms of tau promotes their self-assembly into tangles of PHFs [39] but the contribution of each isoform to tangle formation is not known. In addition, it has recently been reported that tau meditates the synaptic toxicity of Aβ, but the mechanisms are not clear.
Tau Hyperphosphorylation Inhibits Proteases
Polyubiquitylated tau proteins are present in tangles and proteasome activity is decreased in the AD brain [46] .
Inhibition of proteasomes by lactacystin induces phosphorylation and accumulation of tau [47] . The extensive tau hyperphosphorylation induced by inhibition of PP2A
or activation of GSK-3 inhibits proteasomes in HEK293 cells stably expressing human tau 441 , while moderate tau phosphorylation stimulates proteasome activity [48] .
Incubation of proteasomes with PHF-tau isolated from AD brains inhibits their activity [49] , providing direct evidence for the inhibition of proteasomes by tau. It seems that tau hyperphosphorylation and proteasome inhibition can form a vicious cycle, though the causality needs to be clearly established.
The "Neuroprotective" Role of Tau Hyperphosphorylation
Although it is widely believed that tau hyperphosphorylation induces neuron loss, evidence that directly links wild-type tau proteins with cell death is still lacking. Instead, some recent studies suggest that tau hyperphosphorylation and/ or accumulation may be neuroprotective, especially when cells are exposed to an acute insult.
Evidence Supporting the Protective Role of Tau Hyperphosphorylation
By quantitative analysis of neuron loss and neurofi brillary tangle formation as a function of disease duration, it was found that CA1 hippocampal neurons can survive with neurofibrillary tangles for ~20 years [50] . In a transgenic mouse model expressing human mutant P301L tau (rTg4510), neuron loss occurs before neurofi brillary lesions appear in the dentate gyrus and, conversely, neurofi brillary pathology appears without major cell loss in the striatum [51] .
In P301S mice, tau hyperphosphorylation is signifi cant but no apoptosis is detectable [52] . Tau hyperphosphorylation occurs during hibernation, a model of neuroprotection [53, 54] .
With ageing or evolution of AD, neurons in the brain are constantly exposed to an environment with enriched pro-apoptotic factors, such as oxidative stress and Aβ [55] .
However, as noted above, there is surprisingly little evidence for the completion of apoptotic cell death in the AD brain, implying that certain mechanism may allow neurons to escape from apoptosis. Since abnormally hyperphosphorylated tau is the major protein component of the tangles in degenerating neurons of the AD brain at autopsy, researchers believe that tau hyperphosphorylation plays a crucial role in neurodegeneration, but how this happens is not clear.
Mechanisms Underlying the Neuroprotection of Tau Hyperphosphorylation
To understand how the abnormal tau hyperphosphorylation causes neurodegeneration, we expressed exogenous tau proteins in a human embryonic kidney cell line that does not express endogenous tau (HEK293) and a mouse neuroblastoma cell line that expresses very low levels of endogenous tau (N2a) and established lines with stable expression of tau or the vector. We treated these cells and primary hippocampal neurons with different types of pro-apoptotic factors, including staurosporine, camptothecin, hydrogen peroxide, ER stress, Aβ, deathassociated protein kinase-1, and GSK-3β. We found that tau hyperphosphorylation induced by these factors is accompanied by unexpectedly reduced apoptosis compared with controls [56] [57] [58] [59] , while tau dephosphorylation promotes apoptosis through failed dephosphorylation of Bcl-2 [60] .
As a cytoskeleton protein, how is tau phosphorylation and/or accumulation involved in cell viability or apoptotic arrest? Our data showed that tau hyperphosphorylation inhibits the phosphorylation of β -catenin through substrate competition, and the nuclear translocation of unphosphorylated β-catenin primes the expression of survival signals (the nuclear pathway). Tau hyperphosphorylation preserves Bcl-2 and suppresses the release of cytochrome-c from mitochondria into the cytosolic fraction, while also inhibiting Bax expression and caspase-9/3 activity; tau hyperphosphorylation mediated by GSK-3β and Cdk-5 inhibits p53 phosphorylation that may be linked to mitochondrial damage (the mitochondrial pathway). Mitochondrial dysfunction and cellular metabolic deficiency have also been reported in AD patients [61] . Tau hyperphosphorylation upregulates the unfolded protein response in the ER, including elevation of phosphorylated PERK, eIF2, and IRE1 with increased cleavage of ATF6 and ATF4 (the ER pathway) [57] [58] [59] . Furthermore, tau hyperphosphorylation induced by knockdown of the endogenous protein inhibitor of PP2A, namely inhibitor-2 of PP2A, is concomitant with the upregulation of p53
and Akt [56] . Since p53 and Akt serve as pro-and antiapoptotic factors, respectively, we speculate that the anti-apoptotic effects of Akt may overwhelm the proapoptotic role of p53, causing cells to abort apoptosis (Akt/ p53 signaling). Some of the currently verified molecular mechanisms underlying the apoptotic arrest associated with tau hyperphosphorylation are summarized in Fig. 1 .
Further studies are needed to reveal how intracellular tau accumulation affects the expression and/or activitydependent modifi cation of cell factors regulating viability as noted in this review.
Nature of Tau Hyperphosphorylation-associated Neurodegeneration
Based on these fi ndings and the fact that apoptosis is not the major mechanism of cell loss in the AD brain, we have
proposed that hyperphosphorylation of tau may play a dual role in leading neurons to abort acute apoptosis and simultaneously enter chronic degeneration [2] . We believe that tau hyperphosphorylation-associated apoptotic arrest is the first step of neurodegeneration in the AD brain;
in other words, the apoptotic arrest associated with tau hyperphosphorylation triggers neurodegeneration. Our "sick" and destined for chronic neurodegeneration (Fig.   2 ). Therefore, tau hyperphosphorylation/tangle formation allows neurons to escape from acute apoptosis and survive to the end-stage as seen in the AD brain at autopsy.
Our findings reveal the nature of neurodegeneration.
Since there is currently no specific molecular marker to measure neurodegeneration, researchers have used markers of apoptosis or necrosis to detect it. Clearly, neurodegeneration is different from apoptosis, rather, it may be a unique and precisely-regulated form of chronic cell death that we have termed "neurodegenerasis" [2] .
How Should We Evaluate Tau Hyperphosphorylation?
As mature neurons in the adult brain are rarely replenished, apoptotic escape induced by tau phosphorylation may be one of the mechanisms that evolved to allow neurons to survive apoptotic attack and so avoid rapid and massive neuron loss, while the "sick" neurons can wait for a chance to self-repair.
However, "sick" neurons loaded with hyperphosphorylated tau proteins are no longer able to perform normal physiological functions, such as microtubule assembly and axonal transport. Moreover, the extended survival time of these "sick" neurons by apoptotic escape makes them less resistant to environmental/metabolic insults and also allows tangles to evolve from the hyperphosphorylated tau, which leads to slow but progressive retrograde degeneration.
In addition, these "sick" neurons may "infect" neighboring neurons and cause transmissible degeneration through currently unknown mechanisms. Furthermore, since "sick" neurons may not be recognized by the "scavengers" of the brain, these dysfunctional neurons can occupy the limited space and so prohibit neurogenesis, which can normally compensate for neuron loss. Therefore, proper modulation of tau phosphorylation at different stages in the development of AD offers promising opportunities to prevent massive apoptotic neuron loss and to at least slow neurodegeneration.
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